Thymosin Alpha-1 3 mg – Surge of Immune Vitality
Launch Your Immune Research
Imagine a lab where immunity strengthens, infections retreat, and vitality surges. Thymosin Alpha-1 3 mg from Peptide Sciences USA ignites breakthroughs. This thymus-derived peptide enhances T-cell function and modulates immune response, driving transformative studies in infection resistance, cancer therapy, and anti-aging. It's your surge for pioneering research, crafted for visionary researchers like you.
The Science Behind Immune Vitality
Thymosin Alpha-1 (Tα1, sequence: Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn, C129H215N33O55, 3108.3 g/mol) is a synthetic 28-amino-acid peptide identical to the natural thymus hormone. It enhances T-cell differentiation, cytokine production (e.g., interferon), and NK cell activity. In clinical studies, Tα1 (1.6–9.6 mg/week, subcutaneous) improved survival in hepatitis B/C, HIV, cancer, and COVID-19, reducing tumor growth and infection severity.
It has anti-inflammatory effects, promotes tissue repair, and may benefit autoimmune diseases. The 3 mg vial is ideal for injectable research into immune deficiencies, chronic infections, and age-related decline.
Why Thymosin Alpha-1 3 mg Fuels Your Studies
Thymosin Alpha-1 isn't just a peptide—it's a surge that redefines immune research. Here's what makes it shine:
- Immune Enhancement: Boosts T-cell function and cytokine production.
- Infection Resistance: Improves outcomes in hepatitis, HIV, and COVID-19.
- Cancer Support: Reduces tumor growth and enhances therapy response.
- Anti-Aging Benefits: Counters age-related immune decline.
- Top Quality: Crafted by Peptide Sciences USA with 99% purity.
With Thymosin Alpha-1 3 mg, you're not just studying—you're igniting immune vitality breakthroughs.
Product Specifications
Peptide Sciences USA's Thymosin Alpha-1 3 mg is your key to cutting-edge immune research. Here's the breakdown:
- Composition: Contains 3 mg Thymosin Alpha-1 (C129H215N33O55, 3108.3 g/mol).
- Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous injection.
- Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by HPLC and Mass Spectrometry.
- Usage Guidelines: Reconstitute with 1–2 mL bacteriostatic water (1.5–3 mg/mL). Inject 1.6–9.6 mg weekly (split doses) for 4–12 weeks. Dosing is experimental for research only. Use under professional supervision.
- Storage: Store lyophilized powder at -20°C for long-term stability or 4°C for short-term use (up to 6 weeks). After reconstitution, refrigerate at 2–8°C and use within 4 weeks.
- Safety: Common side effects include injection site irritation, nausea, vomiting, tiredness, fever, muscle ache; rare swelling or allergic reactions; oversight required.
This peptide is for research purposes only, driving discoveries in immune and anti-aging health.
Legal Disclaimer
Thymosin Alpha-1 3 mg is supplied for research purposes only and is approved in some countries for specific uses (e.g., Zadaxin for hepatitis), but for research only in the US, per regulations as of 2025. It is banned by the World Anti-Doping Agency (WADA) for performance-enhancing use, per . It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical and clinical research.
Frequently Asked Questions
What is thymosin alpha 1 used for?
Thymosin Alpha-1 is studied for immune modulation in hepatitis B/C, HIV, cancer, and infections like COVID-19.
Who shouldn't take thymosin alpha 1?
It's contraindicated in immunosuppressed (e.g., transplant patients), hypersensitivity, pregnant/breastfeeding without advice, and possibly pediatrics.
What are the benefits of thymosin peptide?
Thymosin peptides enhance T-cell function, cytokine production, and tissue repair, benefiting immunity, wound healing, and inflammation reduction.
What are the side effects of thymosin alpha peptides?
Minimal side effects include injection site irritation, nausea, vomiting, tiredness, fever, muscle ache; rare swelling or allergic reactions.
How is Thymosin Alpha-1 3 mg administered in research?
Reconstitute with 1–2 mL bacteriostatic water (1.5–3 mg/mL). Inject 1.6–9.6 mg weekly (split doses) for 4–12 weeks.
